Association of Atrial Fibrillation and/or Flutter With Adverse Cardiac Outcomes and Mortality in Patients With Wolff-Parkinson-White Syndrome
View abstract on PubMed
Summary
This summary is machine-generated.Patients with Wolff-Parkinson-White (WPW) syndrome and atrial fibrillation/flutter (AF/AFL) face increased risks of adverse cardiac events and death. Early screening and ablation may be crucial for this high-risk group.
Area Of Science
- Cardiology
- Electrophysiology
- Public Health
Background
- Wolff-Parkinson-White (WPW) syndrome involves accessory pathways, potentially causing malignant arrhythmias and sudden cardiac death.
- Atrial fibrillation and/or flutter (AF/AFL) are common arrhythmias associated with WPW syndrome.
- The impact of AF/AFL on cardiac outcomes in WPW patients requires further investigation.
Purpose Of The Study
- To determine the effect of AF/AFL on adverse cardiac outcomes and mortality in patients with WPW syndrome.
- To compare cardiac composite outcomes and mortality rates between WPW patients with and without AF/AFL.
- To identify risk factors associated with adverse events in WPW syndrome.
Main Methods
- A retrospective cohort study of Military Health System patients with WPW syndrome (2014-2019).
- Patients were categorized into subgroups based on the presence or absence of AF/AFL.
- Statistical analyses included Kaplan-Meier curves and Cox proportional models to assess outcomes and mortality.
Main Results
- The study included 35,539 WPW patients; 14.9% had AF/AFL.
- Incidence rates for composite cardiac outcomes and mortality were significantly higher in the AF/AFL subgroup (8.18 vs 4.90 and 4.09 vs 2.13 per 100 person-years, respectively; P < .001).
- Adjusted analyses revealed that AF/AFL was associated with a 12% higher risk of composite outcomes and a 16% higher risk of mortality.
Conclusions
- WPW syndrome patients with AF/AFL exhibit a greater association with adverse cardiac events and mortality.
- More aggressive electrophysiology screening and ablation strategies may be beneficial for WPW patients with AF/AFL.
- This finding underscores the importance of risk stratification and timely intervention in WPW syndrome management.
Related Concept Videos
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per...
Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.1. Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...

